BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 29540641)

  • 1. Management of Anaplastic Thyroid Carcinoma: the Fruits from the ATC Research Consortium of Japan.
    Sugitani I; Onoda N; Ito KI; Suzuki S
    J Nippon Med Sch; 2018; 85(1):18-27. PubMed ID: 29540641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors and treatment outcomes for anaplastic thyroid carcinoma: ATC Research Consortium of Japan cohort study of 677 patients.
    Sugitani I; Miyauchi A; Sugino K; Okamoto T; Yoshida A; Suzuki S
    World J Surg; 2012 Jun; 36(6):1247-54. PubMed ID: 22311136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The anaplastic thyroid carcinoma research consortium of Japan].
    Sugitani I
    Nihon Geka Gakkai Zasshi; 2012 Jul; 113(4):368-72. PubMed ID: 22928442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concept and design of a nationwide prospective feasibility/efficacy/safety study of weekly paclitaxel for patients with pathologically confirmed anaplastic thyroid cancer (ATCCJ-PTX-P2).
    Onoda N; Sugitani I; Higashiyama T; Hara H; Ito K; Kammori M; Sugino K; Suzuki S; Toda K; Yoshida A; Miyauchi A
    BMC Cancer; 2015 Jun; 15():475. PubMed ID: 26091846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-intermediate dose of lenvatinib in anaplastic thyroid cancer is highly effective and safe.
    Barbaro D; Lapi P; Viacava P; Torregrossa L
    BMJ Case Rep; 2020 Dec; 13(12):. PubMed ID: 33370973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies.
    Molinaro E; Romei C; Biagini A; Sabini E; Agate L; Mazzeo S; Materazzi G; Sellari-Franceschini S; Ribechini A; Torregrossa L; Basolo F; Vitti P; Elisei R
    Nat Rev Endocrinol; 2017 Nov; 13(11):644-660. PubMed ID: 28707679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salvage Lenvatinib Therapy in Metastatic Anaplastic Thyroid Cancer.
    Iñiguez-Ariza NM; Ryder MM; Hilger CR; Bible KC
    Thyroid; 2017 Jul; 27(7):923-927. PubMed ID: 28471306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anaplastic thyroid carcinomas incidentally found on postoperative pathological examination.
    Yoshida A; Sugino K; Sugitani I; Miyauchi A
    World J Surg; 2014 Sep; 38(9):2311-6. PubMed ID: 24687351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anaplastic thyroid cancer.
    Ranganath R; Shah MA; Shah AR
    Curr Opin Endocrinol Diabetes Obes; 2015 Oct; 22(5):387-91. PubMed ID: 26313900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of surgery in the management of anaplastic thyroid carcinoma: Korean nationwide multicenter study of 329 patients with anaplastic thyroid carcinoma, 2000 to 2012.
    Baek SK; Lee MC; Hah JH; Ahn SH; Son YI; Rho YS; Chung PS; Lee YS; Koo BS; Jung KY; Lee BJ
    Head Neck; 2017 Jan; 39(1):133-139. PubMed ID: 27534388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of vascular endothelial growth factor receptor 2 and clinical response to lenvatinib in patients with anaplastic thyroid cancer.
    Yamazaki H; Yokose T; Hayashi H; Iwasaki H; Osanai S; Suganuma N; Nakayama H; Masudo K; Rino Y; Masuda M
    Cancer Chemother Pharmacol; 2018 Oct; 82(4):649-654. PubMed ID: 30051190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment and Prognosis of Anaplastic Thyroid Carcinoma: A Clinical Study of 50 Cases.
    Liu TR; Xiao ZW; Xu HN; Long Z; Wei FQ; Zhuang SM; Sun XM; Xie LE; Mu JS; Yang AK; Zhang GP; Fan Y
    PLoS One; 2016; 11(10):e0164840. PubMed ID: 27760217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Safety and Efficacy of Weekly Paclitaxel Administration for Anaplastic Thyroid Cancer Patients: A Nationwide Prospective Study.
    Onoda N; Sugino K; Higashiyama T; Kammori M; Toda K; Ito K; Yoshida A; Suganuma N; Nakashima N; Suzuki S; Tsukahara K; Noguchi H; Koizumi M; Nemoto T; Hara H; Miyauchi A; Sugitani I
    Thyroid; 2016 Sep; 26(9):1293-9. PubMed ID: 27484330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II study of the efficacy and safety of lenvatinib for anaplastic thyroid cancer (HOPE).
    Higashiyama T; Sugino K; Hara H; Ito KI; Nakashima N; Onoda N; Tori M; Katoh H; Kiyota N; Ota I; Suganuma N; Hibi Y; Nemoto T; Takahashi S; Yane K; Ioji T; Kojima S; Kaneda H; Sugitani I; Tahara M
    Eur J Cancer; 2022 Sep; 173():210-218. PubMed ID: 35932627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes of Clinicopathologic Characteristics and Survival Outcomes of Anaplastic and Poorly Differentiated Thyroid Carcinoma.
    Lee DY; Won JK; Lee SH; Park DJ; Jung KC; Sung MW; Wu HG; Kim KH; Park YJ; Hah JH
    Thyroid; 2016 Mar; 26(3):404-13. PubMed ID: 26541309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A long survival patient of anaplastic thyroid carcinoma treated with lenvatinib.
    Hamamoto T; Kono T; Taruya T; Ishino T; Ueda T; Takeno S
    Auris Nasus Larynx; 2022 Jun; 49(3):515-519. PubMed ID: 33109426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spanish consensus for the management of patients with anaplastic cell thyroid carcinoma.
    Gómez Sáez JM; Jiménez-Fonseca P; Santamaría Sandi J; Capdevila Castillón J; Navarro González E; Zafón Llopis C; Ramón Y Cajal Asensio T; Riesco Eizaguirre G; Grande Pulido E; Galofré Ferrater JC
    Endocrinol Nutr; 2015 Mar; 62(3):e15-22. PubMed ID: 25583658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and Effectiveness of Lenvatinib in 594 Patients with Unresectable Thyroid Cancer in an All-Case Post-Marketing Observational Study in Japan.
    Takahashi S; Tahara M; Ito K; Tori M; Kiyota N; Yoshida K; Sakata Y; Yoshida A
    Adv Ther; 2020 Sep; 37(9):3850-3862. PubMed ID: 32676927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological effects of vinorelbine in combination with lenvatinib in anaplastic thyroid cancer.
    Di Desidero T; Orlandi P; Gentile D; Banchi M; Alì G; Kusmic C; Armanetti P; Cayme GJ; Menichetti L; Fontanini G; Francia G; Bocci G
    Pharmacol Res; 2020 Aug; 158():104920. PubMed ID: 32461187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical presentation, treatment and outcome of anaplastic thyroid carcinoma: results of a multicenter study in Germany.
    Wendler J; Kroiss M; Gast K; Kreissl MC; Allelein S; Lichtenauer U; Blaser R; Spitzweg C; Fassnacht M; Schott M; Führer D; Tiedje V
    Eur J Endocrinol; 2016 Dec; 175(6):521-529. PubMed ID: 27926471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.